$86 Profit
SAVALong Stock
Nucleus FDA - Phase 2a data due for Alzheimer’s Disease in Second Half (but possible coming July 14-16 at a conference)
| Date | Price | |
|---|---|---|
| Entry | 7/2/2019 | 1.3277 |
| Exit | 7/2/2019 | 1.3523 |
- Total Views122
- Position Size3,500
- Percentage1.85%
Copy and paste the following into your page or blog. If using WordPress, you must paste this in the HTML tab only:
